Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Deutsche Bank AG (DB) vs Herbalife Nutrition Ltd (HLF) Price & Performance

Deutsche Bank AGTrade
Herbalife Nutrition LtdTrade

Price performance (Past 24H)

Key statistics

Deutsche Bank AG vs Herbalife Nutrition Ltd — how do they compare? Deutsche Bank AG trades at $36.24 (market cap $68.51B), while Herbalife Nutrition Ltd trades at $12.42 (market cap $1.27B). The key difference: Deutsche Bank AG is far larger — about 53.9× Herbalife Nutrition Ltd's market cap, and Deutsche Bank AG pays a 3.26% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals.

DBHLF
Market Cap
$68.51B$1.27B
Sector
FinancialsConsumer Staples
52-Week High
$40.33$19.96
52-Week Low
$28.37$7.75
Dividend Yield
3.26%
Enterprise Value
$3.00B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Deutsche Bank AG

Deutsche Bank (DB) trades at $35.24, down 1.48% on the day, with a bullish technical signal from moving averages and a neutral stance from oscillators. The stock shows attractive valuation metrics with a P/E of 9.79 and P/B of 0.76. Recent quarterly earnings have consistently beaten expectations, and the company announced a $1.00 dividend for H1-26. However, 2024 cash flow was negative $33.10 billion, though it improved to a positive $7.6 billion in 2025.

The outlook is mixed; strong profitability and earnings beats support upside, but regulatory scrutiny and volatile cash flows pose risks. Analyst consensus is cautious with 57.58% hold ratings. The stock's low valuation may appeal to value investors, yet headline risks from recent legal searches require monitoring.

Herbalife Nutrition Ltd

Herbalife (HLF) trades at $13.10, down 0.38% on the day, with a bullish technical signal supported by moving averages. The company maintains strong profitability with a 77.78% gross margin and attractive valuation metrics including a P/E of 5.75 and P/S of 0.27. Recent Q1 2026 earnings beat expectations with EPS of $0.64 versus $0.607 expected, while the company completed a $1.45 billion debt refinancing in April 2026 to strengthen its balance sheet.

The outlook remains positive with analyst consensus favoring Buy ratings (57.69%) and improving debt-to-asset ratios from 82.84% in 2024 to 71.67% in 2025. Key risks include high leverage, competitive pressures in the nutrition space, and regional market volatility. The stock offers value appeal given low multiples and recent strategic initiatives to expand digital health offerings.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Deutsche Bank AG

In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.

Read more on DB

About Herbalife Nutrition Ltd

Herbalife Nutrition Ltd is an international nutrition company.

Read more on HLF